RISK FACTORS FOR SARS-COV-2 INFECTION AND PECULIARITIES OF VIRAL SHEDDING IN PATIENTS WITH SARCOIDOSIS
- Autores: Dobin V.L.1, Panin I.V.1, Martynov V.A.1
-
Afiliações:
- Academician I.P. Pavlov Ryazan State Medical University, Ministry of Health of Russia
- Edição: Volume 12, Nº 2 (2022)
- Páginas: 83-86
- Seção: Articles
- URL: https://journals.eco-vector.com/2226-6976/article/view/287937
- DOI: https://doi.org/10.18565/epidem.2022.12.2.83-6
- ID: 287937
Citar
Texto integral
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
Palavras-chave
Texto integral
Sobre autores
Vitaly Dobin
Academician I.P. Pavlov Ryazan State Medical University, Ministry of Health of Russia
Email: viladob@gmail.com
MD, Professor, Department of Infectious Diseases and Phthisiology Ryazan, Russia
Ilya Panin
Academician I.P. Pavlov Ryazan State Medical University, Ministry of Health of Russia
Email: iliavpanin@gmail.com
Cand. Med. Sci., Assistant Professor, Department of Cardiovascular, X-Ray Endovascular Surgery and Radiodiagnosis Ryazan, Russia
Vladimir Martynov
Academician I.P. Pavlov Ryazan State Medical University, Ministry of Health of Russia
Email: dr.martinov@mail.ru
MD, Head, Department of Infectious Diseases and Phthisiology Ryazan, Russia
Bibliografia
- Добин В.Л., Панин И.В. Саркоидоз и COVID-19. Туберкулез и болезни легких 2021; 99 (8): 7-12. doi.org/10.21292/2075-1230-2021-99-8-7-12
- Визель А.А., Визель И.Ю., Костинов М.Л., Амиров Н.Б. Саркоидоз. Новая инфекция COVID-19 и вопросы вакцинации. Вестник современной клинической медицины 2021; 14 (4): 48-57. DOI: 10.20969/ VKSM.2021.14(4).48-57
- Manansala M., Ascoli C., Alburquerque A.G., Perkins D., Mirsaedi M., Finn P., Sweiss N.J. Case Series: COVID-19 in African American Patients With Sarcoidosis. Front Med. (Lausanne) 2020; (7): 588527. doi: 10.3389/fmed.2020.588527. PMID: 33251236;PMCID: PMC767220
- Morgenthau A.S., Levin M.A., Freeman R., Reich D.L., Klang E. Moderate or Severe Impairment in Pulmonary Function is Associated with Mortality in Sarcoidois Patients Infected with SARS-CoV-2. Lung 2020; 198 (5): 771-5. doi: 10.1007/s00408-020-00392-9
- Baughman R.P., Buchanon M., Rottoli P. et al. Risk and outcome of COVID-19 infection in sarcoidosis patients: results of a self-reporting questionnaire. Sarcoidosis Vasc Lung Dis. 2020; 37: e2020009. doi: 10.36141/svdld.v37i4.10726
- Sweiss N.J., Korsten P., Syed H.J., Syed Aamer, Culver D.A., Sosenko T. et al. When the game changes: guidance to adjust sarcoidosis management during the COVID-19 pandemic. Chest 2020; 158 (3). doi: 10.1016/j.chest.2020.04.033